SCHEMBL19051237

SCHEMBL19051237

CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCCC1

nearest known ligand 0.94

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 16/20 0.94
SLC6A4 P31645 16/20 0.94
SLC6A2 P23975 7/20 0.94
KCNH2 Q12809 3/20 0.94
CHRM2 P08172 1/20 0.94
ADRA2A P08913 1/20 0.94
ADRA2B P18089 1/20 0.94
ADRA2C P18825 1/20 0.94
HTR2A P28223 1/20 0.94
OPRK1 P41145 1/20 0.94
HTR2B P41595 1/20 0.94
CYP3A4 P08684 2/20 0.91
ALOX15 P16050 2/20 0.91
TSHR P16473 2/20 0.91
ALDH1A1 P00352 1/20 0.91
LMNA P02545 1/20 0.91
MAPT P10636 1/20 0.91
MAPK1 P28482 1/20 0.91
TP53 P04637 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sibutramine SCHEMBL3707643 0.97 SLC6A3 (1.00) SLC6A3SLC6A4SLC6A2KCNH2CHRM2
Sibutramine SCHEMBL2955 0.97 SLC6A3 (1.00) SLC6A3SLC6A4SLC6A2KCNH2CHRM2
Sibutramine SCHEMBL2672138 0.97 SLC6A3 (1.00) SLC6A3SLC6A4SLC6A2KCNH2CHRM2
Sibutramine SCHEMBL16312 0.97 SLC6A3 (1.00) SLC6A3SLC6A4SLC6A2KCNH2CHRM2
Sibutramine SCHEMBL1598 0.95 CYP3A4 (1.00) SLC6A3SLC6A4SLC6A2KCNH2CHRM2
Sibutramine SCHEMBL7626175 0.95 CYP3A4 (1.00) SLC6A3SLC6A4SLC6A2KCNH2CHRM2
Sibutramine SCHEMBL6431587 0.95 SLC6A3 (0.97) SLC6A3SLC6A4SLC6A2KCNH2CHRM2
Sibutramine SCHEMBL7191483 0.95 CYP3A4 (1.00) SLC6A3SLC6A4SLC6A2KCNH2CHRM2
Sibutramine SCHEMBL7189499 0.95 CYP3A4 (1.00) SLC6A3SLC6A4SLC6A2KCNH2CHRM2
Sibutramine SCHEMBL2916993 0.95 SLC6A3 (0.97) SLC6A3SLC6A4SLC6A2KCNH2CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017112701-A1 METABOLISM RESISTANT FENFLURAMINE ANALOGS AND METHODS OF USING THE SAME ZOGENIX INTERNATIONAL LIMITED (GB) 2017-06-29 WO disclosed